Wednesday, September 16, 2026Latest filing Sep 14, 2026

IBDQ Congressional Stock Trades

Dec 2025 Term Corp Ishares Ibonds ETF

Last disclosed trade Dec 18

Every disclosed trade in IBDQ by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Lindsey Graham · Sold $IBDQ · Dec 18 · $15K–$50K

0.45LOW
Disclosure speedx 0.250.60
Trade sizex 0.250.50
Cluster activityx 0.150.00
Track recordx 0.35default0.50

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow $IBDQ

Get notified when any member of Congress trades $IBDQ. Free, no card, no spam.

Follow free →
1
Disclosed trades
0
Buys
1
Sells
1
Members trading

The record on $IBDQ

Coldpine has parsed 1 disclosed trade in $IBDQ by 1 member of Congress, drawn from 1 periodic transaction report dated Dec 18, 2025. It came from the Senate, filed by a Republican.

The one trade with a known filing lag was reported 19 days after the trade date, inside the 45-day window the STOCK Act sets: a $IBDQ sale by Lindsey Graham dated Dec 18, 2025, disclosed Jan 6, 2026. How late filing is measured across all of Congress is in the late-filers study.

The one trade that lists an account holder was reported under the member directly, not a spouse, dependent child, or joint account.

Members who trade IBDQ

Recent disclosed trades in IBDQ

DateMemberTypeAmount
Dec 18Lindsey Graham(SC)sell$15K–$50K

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →